
The acquisition brings Gallant’s experimental stem cell treatments for chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Print this PDF for a handy index to articles, subjects, and authors in every 2009 issue of Veterinary Economics.

